I explained to him that I'm concerned that the technology might ruin the eggs (and thus cause the demise of our embies) like it did in our last failure of a cycle and he said that he didn't think it would. He said that if we had just 1 embryo, he'd suggest we move forward with the PBB/CGH genetic testing.
I suggested to him that it seemed that he had better results on fresh cycles than they do on the PBB/CGH cycles so why would anyone opt to do PBB/CGH when they could do fresh? ...
FRESH CYCLES : 2007 SART reports indicate that 40 year olds cycling at CCRM have a 50% chance at clinical pregnancy.
CGH/PBB CYCLES: this group is on average 40 years old and CCRM is reporting a 22% clinical pregnancy rate.
Edited to add: 22% success is for PBB/CGH not blastocyst CGH (which has an 84% success rate). These stats are of clinical pregnancy rate and not live birth rate b/c they do not have live birth numbers for this new PBB/CGH technology.
Schooly indicated that you can't compare these two groups. 40 year olds who do PBB/CGH are women who probably should be using donor eggs where as the women who do the fresh cycles aren't at the stage where they need donor eggs yet.
I asked him what his success rate was for pregnancies from frozen oocytes (as this is likely the MOST delicate procedure that could harm the eggs) and he said that their pregnancy rate is the same from vitrified oocytes as it is with fresh oocytes ... the same.
Lastly, he said he wasn't even sure why we were asking this question. He really doesn't anticipate that we will yield a low mature oocyte count. Dr. Schoolcraft said he was confident we would get a lot of eggs - I told him that I'd rather operate in the realities of my life ... get that? Me, I was the one being all stern with bad bedside manners and HE was the one all emotional and optimistic! (This is funny for anyone who's spoken with or met Dr. Schoolcraft ... he's not exactly warm and fuzzy.)
So Berilac and I have until trigger day to decide which technology we will use ... straight fresh IVF or PBB/CGH while vitrifying oocytes.